Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Initial interactions with the FDA on developing a validation dataset as a medical device development tool

The Journal of Pathology(2023)10.1002/path.6208Source: DataRank Database

Initial interactions with the FDA on developing a validation dataset as a medical device development tool is a research paper published in The Journal of Pathology (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.28)OA: hybridTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Víctor García ORCID,Sarah Dudgeon ORCID,Matthew G. Hanna ORCID,Xiaoxian Li ORCID,Kim Blenman ORCID

Live enrichment

PubMed:37794720 PMC:PMC10841854 OpenAlex:https://openalex.org/W4387357945

Food and Drug Administration

Grant: FD005938

Intramural FDA HHS

Grant: FD999999

NCATS NIH HHS

Grant: UL1 TR001863

FDA HHS

Grant: U01 FD005938

Emory University

Stony Brook University

Yale University

FWCI

0.28

Citation Percentile

0.6%

Citation Trend

2024

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.6208

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.6208

publisherhttps://pathsocjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/path.6208

journalhttps://doi.org/10.1002/path.6208

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37794720

Fields of Study

AI in cancer detectionRadiomics and Machine Learning in Medical ImagingBreast Cancer Treatment StudiesUnited StatesHumansUnited States Food and Drug AdministrationPathologistsLymphocytes, Tumor-InfiltratingUnited Kingdom

MeSH Terms

PathologistsUnited KingdomHumansUnited StatesUnited States Food and Drug AdministrationLymphocytes, Tumor-Infiltrating

Keywords

Computer scienceContext (archaeology)DocumentationComputational modelProcess (computing)Task (project management)Data scienceFood and drug administrationArtificial intelligenceRisk analysis (engineering)MedicineModel validationMachine LearningTriple-negative Breast CancerTumor-infiltrating LymphocytesRegulatory ScienceComputational PathologyMedical Device Development Tool

Sustainable Development Goals

SDG 0: Partnerships for the goals